Using acute optic neuritis trials to assess neuroprotective and remyelinating therapies in multiple sclerosis

M Andorra, S Alba-Arbalat, A Camos-Carreras… - JAMA …, 2020 - jamanetwork.com
Importance Neuroprotective and remyelinating therapies are required for multiple sclerosis
(MS), and acute optic neuritis (AON) is a potential condition to evaluate such treatments …
被引用次数：29 相关文章
[HTML] nih.gov

[HTML][HTML] Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis

M Andorrà, S Alba-Arbalat, A Camos-Carreras… - JAMA …, 2020 - ncbi.nlm.nih.gov
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in
Multiple Sclerosis - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis

M Andorrà, S Alba-Arbalat… - JAMA …, 2020 - pubmed.ncbi.nlm.nih.gov
Importance Neuroprotective and remyelinating therapies are required for multiple sclerosis
(MS), and acute optic neuritis (AON) is a potential condition to evaluate such treatments …

Using acute optic neuritis trials to assess neuroprotective and remyelinating therapies in multiple sclerosis

M Andorra, S Alba-Arbalat, A Camos Carreras… - 2020 - repositorio.uchile.cl
Importance Neuroprotective and remyelinating therapies are required for multiple sclerosis
(MS), and acute optic neuritis (AON) is a potential condition to evaluate such treatments …

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

M Andorrà, S Alba-Arbalat, A Camos-Carreras… - JAMA …, 2020 - europepmc.org
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in
Multiple Sclerosis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

M Andorrà, S Alba-Arbalat… - JAMA …, 2020 - search.ebscohost.com
Abstract Key Points: Question: May acute optic neuritis help to assess neuroprotection and
remyelination? Findings: This cohort study found that trials testing neuroprotection using …

Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

M Andorrà, S Alba-Arbalat, A Camos-Carreras… - JAMA …, 2020 - europepmc.org
Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in
Multiple Sclerosis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …